Ryan Peter J, Patel Nirmal P
Department of Otolaryngology and Head and Neck Surgery, Royal North Shore Hospital, St Leonards, NSW, Australia.
Kolling Deafness Research Centre, Macquarie University and University of Sydney, NSW, Australia.
J Otol. 2020 Mar;15(1):17-26. doi: 10.1016/j.joto.2018.11.009. Epub 2018 Dec 3.
Pediatric cholesteatoma occurs in one of two forms: congenital cholesteatoma, developing from embryonic epidermal cell rests or acquired cholesteatoma, associated with a focal defect in the tympanic membrane. This disease has been traditionally managed with the operating microscope, often requiring mastoidectomy for adequate visualization of and access to the middle ear and mastoid cavities. Recently, advances in endoscopic equipment have enabled otologists to manage most cases of pediatric cholesteatoma via a minimally-invasive, transcanal endoscopic approach. This review discusses the current literature relating to the etiopathogenesis, assessment and endoscopic management of pediatric cholesteatoma. Early outcomes of endoscopic treatment, emerging trends and technologies are also reviewed.
先天性胆脂瘤,由胚胎表皮细胞残余发展而来;或后天性胆脂瘤,与鼓膜的局灶性缺损相关。传统上,这种疾病通过手术显微镜进行治疗,通常需要进行乳突切除术以充分观察和进入中耳及乳突腔。最近,内镜设备的进步使耳科医生能够通过微创经耳道内镜方法处理大多数小儿胆脂瘤病例。本文综述了有关小儿胆脂瘤的病因发病机制、评估及内镜治疗的当前文献。还综述了内镜治疗的早期结果、新出现的趋势和技术。